Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display
- PMID: 9664085
- PMCID: PMC508902
- DOI: 10.1172/JCI3008
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display
Abstract
Vascular beds are known to differ in structure and metabolic function, but less is known about their molecular diversity. We have studied organ-specific molecular differences of the endothelium in various tissues by using in vivo screening of peptide libraries expressed on the surface of a bacteriophage. We report here that targeting of a large number of tissues with this method yielded, in each case, phage that homed selectively to the targeted organ. Different peptide motifs were recovered from each of these tissues. The enrichment in homing to the target organs relative to an unselected phage was 3-35-fold. Peptide sequences that conferred selective phage homing to the vasculature of lung, skin, and pancreas were characterized in detail. Immunohistochemistry showed that the phage localized in the blood vessels of their target organ. When tested, the phage homing was blocked in the presence of the cognate peptide. By targeting several tissues and by showing that specific homing could be achieved in each case, we provide evidence that organ- and tissue-specific molecular heterogeneity of the vasculature is a general, perhaps even universal, phenomenon. Our results also show that these molecular differences can serve as molecular addresses.
Similar articles
-
Organ targeting in vivo using phage display peptide libraries.Nature. 1996 Mar 28;380(6572):364-6. doi: 10.1038/380364a0. Nature. 1996. PMID: 8598934
-
Vascular targeting with phage peptide libraries.Q J Nucl Med. 1999 Jun;43(2):159-62. Q J Nucl Med. 1999. PMID: 10429511 Review.
-
Identification of synovium-specific homing peptides by in vivo phage display selection.Arthritis Rheum. 2002 Aug;46(8):2109-20. doi: 10.1002/art.10464. Arthritis Rheum. 2002. PMID: 12209516
-
Targeting the prostate for destruction through a vascular address.Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1527-31. doi: 10.1073/pnas.241655998. Proc Natl Acad Sci U S A. 2002. PMID: 11830668 Free PMC article.
-
Molecular addresses of tumors: selection by in vivo phage display.Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):177-81. doi: 10.1007/s00005-006-0026-y. Epub 2006 May 31. Arch Immunol Ther Exp (Warsz). 2006. PMID: 16736105 Review.
Cited by
-
Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.Front Immunol. 2013 Jan 9;3:419. doi: 10.3389/fimmu.2012.00419. eCollection 2012. Front Immunol. 2013. PMID: 23316203 Free PMC article.
-
Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease.Mol Ther. 2012 Jul;20(7):1393-9. doi: 10.1038/mt.2012.100. Epub 2012 May 15. Mol Ther. 2012. PMID: 22588273 Free PMC article.
-
Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature.Blood. 2005 Dec 15;106(13):4191-8. doi: 10.1182/blood-2005-05-2002. Epub 2005 Sep 6. Blood. 2005. PMID: 16144802 Free PMC article.
-
The in vivo endothelial cell translatome is highly heterogeneous across vascular beds.Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23618-23624. doi: 10.1073/pnas.1912409116. Epub 2019 Nov 11. Proc Natl Acad Sci U S A. 2019. PMID: 31712416 Free PMC article.
-
Vascular targeting: recent advances and therapeutic perspectives.Trends Cardiovasc Med. 2006 Apr;16(3):80-8. doi: 10.1016/j.tcm.2006.01.003. Trends Cardiovasc Med. 2006. PMID: 16546688 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources